Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment

NCT03770260 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: Ixazomib Citrate
DRUG: Pevonedistat

Sponsor

National Cancer Institute (NCI)